ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
10.16
+0.15 (1.50%)
At close: May 22, 2026, 4:00 PM EDT
10.12
-0.04 (-0.39%)
After-hours: May 22, 2026, 4:10 PM EDT

ImmuCell Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
6.813.813.760.985.7910.19
Cash & Short-Term Investments
6.813.813.760.985.7910.19
Cash Growth
48.12%1.29%283.99%-83.10%-43.14%28.18%
Accounts Receivable
2.693.423.772.191.762.69
Inventory
8.679.277.117.816.043.09
Other Current Assets
0.680.450.40.490.410.3
Total Current Assets
18.8616.9415.0411.4713.9916.26
Net Property, Plant & Equipment
25.1225.4529.9132.1530.6428
Other Intangible Assets
--0.020.040.060.08
Goodwill
0.10.10.10.10.10.1
Other Long-Term Assets
0.030.040.030.060.080.03
Total Assets
44.1142.5345.143.8144.8644.47
Accounts Payable
2.22.282.482.1221.61
Current Portion of Long-Term Debt
1.631.611.51.431.040.81
Current Portion of Leases
0.090.090.430.640.030.11
Total Current Liabilities
3.913.984.414.23.072.53
Long-Term Debt
7.077.499.0410.549.198.33
Long-Term Leases
3.994.014.134.082.221.03
Total Long-Term Liabilities
11.0611.513.1714.6211.419.35
Total Liabilities
14.9715.4817.5818.8214.4811.89
Common Stock
0.910.910.90.780.780.78
Treasury Stock
-0.19-0.13-0.14-0.14-0.15-0.16
Additional Paid-in Capital
41.6841.4840.9236.3635.9835.69
Retained Earnings
-13.26-15.2-14.16-12.01-6.23-3.74
Shareholders' Equity
29.1427.0627.5224.9930.3832.58
Total Liabilities & Equity
44.1142.5345.143.8144.8644.47
Total Debt
12.7813.1915.116.6912.4810.27
Net Cash (Debt)
-5.96-9.39-11.34-15.71-6.69-0.09
Net Cash Per Share
-0.66-1.04-1.39-2.03-0.86-0.01
Book Value
29.1427.0627.5224.9930.3832.58
Book Value Per Share
3.223.003.373.233.924.29
Tangible Book Value
29.0426.9627.424.8630.2332.41
Tangible Book Value Per Share
3.212.993.363.213.904.27
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q